Certified Advisory Corp’s GSK GSK Stock Holding History

Certified Advisory Corp’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-486	Closed	-$22K	–	416
2021 Q1	$22K	Buy	+486	New	+$22.1K	0.01%	476
2020 Q2	$24K	Hold	462	–	–	0.01%	407
2020 Q1	$22K	Hold	462	–	–	0.01%	395
2019 Q4	$27K	Sell	462 -1,842	-80%	-$102K	0.01%	417
2019 Q3	$123K	Buy	2,304 +2	+0.1%	+$103	0.04%	217
2019 Q2	$115K	Sell	2,302 -319	-12%	-$16K	0.04%	218
2019 Q1	$137K	Buy	2,621 +2	+0.1%	+$100	0.06%	187
2018 Q4	$125K	Sell	2,619 -2,775	-51%	-$137K	0.06%	180
2018 Q3	$271K	Sell	5,394 -5,409	-50%	-$275K	0.13%	131
2018 Q2	$544K	Sell	10,803 -863	-7%	-$43.5K	0.3%	80
2018 Q1	$569K	Buy	11,666 +9,532	+447%	+$444K	0.34%	76
2017 Q4	$94K	Buy	+2,134	New	+$98.6K	0.07%	166

Other funds holding GSK

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.78B AUM 5.83% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Certified Advisory Corp's GSK Position: Q2 2021 in Review

Certified Advisory Corp sold out of GSK (GSK) in Q2 2021, closing a stake of 486 shares — an estimated $22K sold.

Certified Advisory Corp first reported a position in GSK in Q4 2017 and held it in 12 quarters. The position peaked at $569K in Q1 2018. 799 funds tracked by Wall St. Rank hold GSK as of Q2 2021.

Certified Advisory Corp reported no remaining GSK position as of Q2 2021 after selling out during the quarter.
Certified Advisory Corp sold 486 GSK shares in Q2 2021, an estimated $22K.
Certified Advisory Corp first reported a position in GSK in Q4 2017 and held it in 12 quarters.
Certified Advisory Corp's GSK position peaked at $569K in Q1 2018.
799 funds tracked by Wall St. Rank held GSK as of Q2 2021.

Based on Certified Advisory Corp's 13F filing for Q2 2021, filed 16 Aug 2021.